West Chester, PA, United States of America

Luigi Anzalone

USPTO Granted Patents = 23 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.8

ph-index = 10

Forward Citations = 178(Granted Patents)

Company Filing History:

8 out of 2,076

Janssen Pharmaceutica Nv

patents

4 out of 106

Dupont Pharmaceuticals Company

patents

4 out of 4

Furiex Pharmaceuticals, Inc.

patents

4. 2 out of 44

Alios Biopharma, Inc.

patents

5. 2 out of 1,149

Vertex Pharmaceuticals, Inc.

patents

6. 2 out of 234

Bristol-myers Squibb Pharma Company

patents

7. 1 out of 1

Forest Tosara Limited

patent

8. 1 out of 3,681

Bristol-myers Squibb Compnay

patents

9. 1 out of 11

Allergan Holdings Unlimited Company

patents

where one patent can have more than one assignee

Years Active: 1999-2017

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9789125 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2017-10-17),

2. 9364489 - Crystals and process of making 5-({[2-amino-3-(4-Carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2016-06-14),

3. 9187408 - Process for the preparation of protected L-alanine derivatives (2015-11-17),

4. 9115091 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl—1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2015-08-25),

5. 8895723 - Methods of preparing substituted nucleotide analogs (2014-11-25),

6. 8859604 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2014-10-14),

7. 8853445 - Process for the preparation of protected L-alanine derivatives (2014-10-07),

8. 8846896 - Methods of preparing substituted nucleotide analogs (2014-09-30),

9. 8710256 - Process for the preparation of protected L-alanine derivatives (2014-04-29),

10. 8691860 - Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2014-04-08),

11. 8609865 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2013-12-17),

12. 8378122 - Process for the preparation of chymase modulators (2013-02-19),

13. 8263785 - Process for the preparation of chymase modulators (2012-09-11),

14. 8222431 - Process for synthesizing phosphonic and phosphinic acid compounds (2012-07-17),

15. 7994206 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid (2011-08-09),

Title: Luigi Anzalone – A Pioneer in Pharmaceutical Innovations

Luigi Anzalone is a prominent inventor based in West Chester, PA, who has made significant contributions to the pharmaceutical industry through his extensive research and innovative ideas. With a remarkable portfolio of 23 patents, Anzalone stands out as a key figure in the realm of drug development and formulation.

Latest Patents

Among his latest inventions, Anzalone has developed unique methods and processes for creating novel crystals of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid. This invention not only enhances the crystallization processes but also improves the performance of this compound as a zwitterion. His dedication to advancing pharmaceutical formulations is evident through this complex yet essential invention.

Career Highlights

Luigi Anzalone has worked for several reputable companies in the pharmaceutical sector, including Janssen Pharmaceutica and DuPont Pharmaceuticals Company. These roles have allowed him to hone his skills and contribute significantly to the development of innovative pharmaceutical solutions that address critical medical needs.

Collaborations

Throughout his career, Anzalone has collaborated with esteemed colleagues such as Frank John Villani, Jr. and Penina Feibush. These collaborations reflect a commitment to teamwork and the sharing of knowledge that fuels innovation in the pharmaceutical field.

Conclusion

In conclusion, Luigi Anzalone’s work exemplifies the impact that dedicated inventors can have on the pharmaceutical industry. His inventions and collaborations continue to push the boundaries of what is possible, and his legacy as an innovator will undoubtedly inspire future generations of scientists and researchers.

This text is generated by artificial intelligence and may not be accurate.